Skip to main content
Nita Seibel, MD, Pediatric Hematology & Oncology, Rockville, MD, Children's National Hospital

NitaLSeibelMD

Pediatric Hematology & Oncology Rockville, MD

Head, Pediatric Solid Tumor Therapeutics

Dr. Seibel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Seibel's full profile

Already have an account?

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1984 - 1987
  • National Capital Consortium
    National Capital ConsortiumResidency, Pediatrics, 1984 - 1986
  • Nationwide Children's Hospital/Ohio State University
    Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 1981 - 1983
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1981

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1987 - 2026
  • MD State Medical License
    MD State Medical License 1988 - 2025
  • VA State Medical License
    VA State Medical License 1988 - 2018
  • DC State Medical License
    DC State Medical License 1988 - 2014
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dexrazoxane Protects the Heart Long Term for Kids Being Treated for Cancer
    Dexrazoxane Protects the Heart Long Term for Kids Being Treated for CancerMarch 16th, 2023
  • FDA Committee Unanimously Rejects 131-I-Omburtamab for Neuroblastoma
    FDA Committee Unanimously Rejects 131-I-Omburtamab for NeuroblastomaOctober 28th, 2022
  • NCI-COG Pediatric MATCH Study Shows Benefit of Genetic Screening in Refractory Tumors
    NCI-COG Pediatric MATCH Study Shows Benefit of Genetic Screening in Refractory TumorsApril 4th, 2022
  • Join now to see all

Hospital Affiliations